Dreger, P., Fenske, T. S., Montoto, S., Pasquini, M. C., Sureda, A., & Hamadani, M. (2020). Cellular immunotherapy for refractory DLBCL in the CART era: Still a role for allogeneic transplantation? Biol Blood Marrow Transplant.
Citação norma ChicagoDreger, Peter, Timothy S. Fenske, Silvia Montoto, Marcelo C. Pasquini, Anna Sureda, and Mehdi Hamadani. "Cellular Immunotherapy for Refractory DLBCL in the CART Era: Still a Role for Allogeneic Transplantation?" Biol Blood Marrow Transplant 2020.
Citação norma MLADreger, Peter, et al. "Cellular Immunotherapy for Refractory DLBCL in the CART Era: Still a Role for Allogeneic Transplantation?" Biol Blood Marrow Transplant 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.